Hyeong Gun Lee has a stellar reputation in the jurisdiction with respondents highlighting him for his superb handling of international M&A transactions and joint ventures.
Hyeong Gun Lee is a senior partner of the corporate/M&A practice group at Lee & Ko. He also serves as a member of Lee & Ko’s management committee since 2018.
With more than 25 years of practice experience, he has advised numerous domestic and foreign clients on a wide range of corporate and business law matters, especially focusing on M&A transactions, including domestic and cross-border stock deals, mergers, spin-offs, business transfers, joint ventures, private equity investments, foreign direct investments and hostile takeovers. Mr Lee has been recognised as a leading lawyer in corporate and M&A by Chambers Asia, Chambers Global (2014-2019), IFLR1000 (2019) and The Legal 500 Asia-Pacific (2019).
His clients include major companies in a broad spectrum of industries - petrochemicals, electronics, manufacturing, financial sectors, heavy industries and others. Notably, as the co-head of Lee & Ko’s life sciences and healthcare practice, he has extensive experience in the fields of life sciences/healthcare and has assisted many major Korean and multinational pharmaceutical, medical device and food companies on various regulatory, corporate and license issues as well as investments and business transactions.
Mr Lee received degrees from Seoul National University College of Law (LLB, 1992) and Columbia University School of Law (LLM, 2002). He worked as a foreign legal consultant at McDermott, Will & Emery, New York (2002), and Sinclair Roche & Temperley, London (1997). He has been a member of the Korean Bar Association and the Seoul Bar Association since 1994. He also passed the New York State Bar Exam in 2002. He is fluent both in Korean and English.